Vaccines in Civilian Defense Against Bioterrorism

publication

Author Information

Author(s): Philip K. Russell

Primary Institution: Johns Hopkins School of Public Health

Can vaccines effectively protect the civilian population against bioterrorism threats?

Vaccines cannot be considered a first line of defense against bioterrorism for the general population due to high costs and logistical challenges.

Vaccination is an effective means of countering known threats for the military.
Vaccines against anthrax and smallpox are available but face challenges in civilian use.
The current anthrax vaccine requires multiple doses, making it less practical for civilian use.

Vaccines are great for protecting people from diseases, but using them to protect everyone from bioterrorism is really hard and expensive.

High costs and difficulties in vaccinating large populations limit the use of vaccines for bioterrorism defense.

Access the complete publication on the publisher's website